For: | Konstantopoulou A, Tsikrikas S, Asvestas D, Korantzopoulos P, Letsas KP. Mechanisms of drug-induced proarrhythmia in clinical practice. World J Cardiol 2013; 5(6): 175-185 [PMID: 23847724 DOI: 10.4330/wjc.v5.i6.175] |
---|---|
URL: | https://www.wjgnet.com/1949-8462/full/v5/i6/175.htm |
Number | Citing Articles |
1 |
Konstantinos Vlachos, Stamatis Georgopoulos, Michael Efremidis, Antonios Sideris, Konstantinos P Letsas. An update on risk factors for drug-induced arrhythmias. Expert Review of Clinical Pharmacology 2016; 9(1): 117 doi: 10.1586/17512433.2016.1100073
|
2 |
Gheorghe-Andrei Dan, Antoni Martinez-Rubio, Stefan Agewall, Giuseppe Boriani, Martin Borggrefe, Fiorenzo Gaita, Isabelle van Gelder, Bulent Gorenek, Juan Carlos Kaski, Keld Kjeldsen, Gregory Y H Lip, Bela Merkely, Ken Okumura, Jonathan P Piccini, Tatjana Potpara, Birgitte Klindt Poulsen, Magdi Saba, Irina Savelieva, Juan L Tamargo, Christian Wolpert, Christian Sticherling, Joachim R Ehrlich, Richard Schilling, Nikola Pavlovic, Tom De Potter, Andrzej Lubinski, Jesper Hastrup Svendsen, Keong Ching, John Lewis Sapp, Carol Chen-Scarabelli, Felipe Martinez. Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP). EP Europace 2018; 20(5): 731 doi: 10.1093/europace/eux373
|
3 |
Francisco Sandro Menezes‐Rodrigues, José Gustavo Padrão Tavares, Marcelo Pires de Oliveira, Rafael Guzella de Carvalho, Paolo Ruggero Errante, Murched Omar Taha, Djalma José Fagundes, Afonso Caricati‐Neto. Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID‐19 patients. Journal of Thrombosis and Haemostasis 2020; 18(8): 2073 doi: 10.1111/jth.14902
|
4 |
Tobias Bruegmann, Patrick M. Boyle, Franziska Schneider-Warme. Heart Rate and Rhythm. 2023; : 359 doi: 10.1007/978-3-031-33588-4_17
|
5 |
Hendrik Lapp, Tobias Bruegmann, Daniela Malan, Stephanie Friedrichs, Carsten Kilgus, Alexandra Heidsieck, Philipp Sasse. Frequency-dependent drug screening using optogenetic stimulation of human iPSC-derived cardiomyocytes. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-09760-7
|
6 |
Lars Eckardt, Günter Breithardt. Cardiac Electrophysiology: From Cell to Bedside. 2018; : 962 doi: 10.1016/B978-0-323-44733-1.00101-2
|
7 |
Susanne Rehnelt, Daniela Malan, Krisztina Juhasz, Benjamin Wolters, Leo Doerr, Matthias Beckler, Ralf Kettenhofen, Heribert Bohlen, Tobias Bruegmann, Philipp Sasse. Frequency-Dependent Multi-Well Cardiotoxicity Screening Enabled by Optogenetic Stimulation. International Journal of Molecular Sciences 2017; 18(12): 2634 doi: 10.3390/ijms18122634
|
8 |
Sai Dheeraj Gutlapalli, Vamsi Krishna Lavu, Rana Abdelwahab Mohamed, Ruimin Huang, Shanthi Potla, Sushen Bhalla, Yousif Al Qabandi, Savitri Aninditha Nandula, Chinmayi Sree Boddepalli, Pousette Hamid. The Risk of Fatal Arrhythmias in Post-Myocardial Infarction Depression in Association With Venlafaxine. Cureus 2022; doi: 10.7759/cureus.29107
|
9 |
Diogo Ramalho, João Freitas. Drug-induced life-threatening arrhythmias and sudden cardiac death: A clinical perspective of long QT, short QT and Brugada syndromes. Revista Portuguesa de Cardiologia 2018; 37(5): 435 doi: 10.1016/j.repc.2017.07.010
|
10 |
Cristobal Manuel Rodríguez-Leal, Elena López-Lunar, Jose Manuel Carrascosa-Bernáldez, Rosa Maria Provencio-Arranz. Electrocardiographic surveillance in a psychiatric institution: avoiding iatrogenic cardiovascular death. International Journal of Psychiatry in Clinical Practice 2017; 21(1): 64 doi: 10.1080/13651501.2016.1234623
|
11 |
Aneesh Karkhanis, Yanjun Hong, Eric Chun Yong Chan. Inhibition and inactivation of human CYP2J2: Implications in cardiac pathophysiology and opportunities in cancer therapy. Biochemical Pharmacology 2017; 135: 12 doi: 10.1016/j.bcp.2017.02.017
|
12 |
Jonas Lantz, Lilian Henriksson, Anders Persson, Matts Karlsson, Tino Ebbers. Patient-Specific Simulation of Cardiac Blood Flow From High-Resolution Computed Tomography. Journal of Biomechanical Engineering 2016; 138(12) doi: 10.1115/1.4034652
|
13 |
Michael Sampson. Antiarrhythmic drugs. Part 1: an overview. British Journal of Cardiac Nursing 2019; 14(9): 1 doi: 10.12968/bjca.2019.0057
|
14 |
Qian Chen, Hong‐jie Qian, Wei Wang, Meng‐qi Zhang, Dong‐ying Lu, Chuan Lu, Jie‐mei Jin, Chao‐ying Hu, Gang‐yi Liu, Jing‐ying Jia, Hong‐chao Zheng, Xue‐ning Li, Chen Yu, Yi‐ping Wang, Yun Liu. Pharmacokinetics, safety, and tolerability of sulcardine sulfate: an open‐label, single‐dose, randomized study in healthy Chinese subjects. Fundamental & Clinical Pharmacology 2017; 31(1): 120 doi: 10.1111/fcp.12242
|
15 |
A. Biffi, F. Rea, L. Scotti, A. Mugelli, E. Lucenteforte, A. Bettiol, A. Chinellato, G. Onder, C. Vitale, N. Agabiti, G. Trifirò, G. Roberto, G. Corrao. Antidepressants and the risk of arrhythmia in elderly affected by a previous cardiovascular disease: a real-life investigation from Italy. European Journal of Clinical Pharmacology 2018; 74(1): 119 doi: 10.1007/s00228-017-2352-x
|
16 |
Makoto Suzuki, Wataru Nagahori, Akira Mizukami, Akihiko Matsumura, Yuji Hashimoto. A multicenter observational study of the effectiveness of antiarrhythmic agents in ventricular arrhythmias: A propensity‐score adjusted analysis. Journal of Arrhythmia 2016; 32(3): 186 doi: 10.1016/j.joa.2016.01.004
|
17 |
Liangyu Zhang, Leilei Gu, Hongqun Qiao. 26‐Week Repeated‐Dose Toxicity Study of a Novel Antiarrhythmic Drug Sulcardine Sulfate in Sprague–Dawley Rats. Journal of Applied Toxicology 2025; doi: 10.1002/jat.4750
|
18 |
Jianting Gong, Yongbing Chen, Feng Pu, Pingping Sun, Fei He, Li Zhang, Yanwen Li, Zhiqiang Ma, Han Wang. Understanding Membrane Protein Drug Targets in Computational Perspective. Current Drug Targets 2019; 20(5): 551 doi: 10.2174/1389450120666181204164721
|
19 |
Wei Wang, Hong-jie Qian, Liang Xin, Meng-qi Zhang, Dong-ying Lu, Jie-mei Jin, Gang-yi Liu, Jing-ying Jia, Hong-chao Zheng, Chen Yu, Yi-ping Wang, Fu Zhu, Yun Liu. Multiple Dose Pharmacokinetics and Safety of Sulcardine Sulfate in Healthy Chinese Male Subjects: An Open-Label Phase I Clinical Study. European Journal of Drug Metabolism and Pharmacokinetics 2017; 42(4): 593 doi: 10.1007/s13318-016-0370-1
|
20 |
Gonçalo Tomé, João Freitas. Induced Brugada syndrome: Possible sources of arrhythmogenesis. Revista Portuguesa de Cardiologia 2017; 36(12): 945 doi: 10.1016/j.repc.2017.06.015
|
21 |
Diogo Ramalho, João Freitas. Drug-induced life-threatening arrhythmias and sudden cardiac death: A clinical perspective of long QT, short QT and Brugada syndromes. Revista Portuguesa de Cardiologia (English Edition) 2018; 37(5): 435 doi: 10.1016/j.repce.2017.07.010
|
22 |
Yan Huang, Yong Xu, Hector Barajas‐Martinez, Dan Hu. Acquired short QT syndrome in a cancer patient treated with Toad. Pacing and Clinical Electrophysiology 2019; 42(9): 1273 doi: 10.1111/pace.13708
|
23 |
J. Rick Turner, Dilip R. Karnad, Christopher H. Cabell, Snehal Kothari. Recent developments in the science of proarrhythmic cardiac safety of new drugs. European Heart Journal - Cardiovascular Pharmacotherapy 2017; 3(2): 118 doi: 10.1093/ehjcvp/pvw045
|
24 |
Antoni Martínez-Rubio, Gheorghe-Andrei Dan. Antiarrhythmic Drugs. 2020; : 379 doi: 10.1007/978-3-030-34893-9_8
|
25 |
Gonçalo Tomé, João Freitas. Induced Brugada syndrome: Possible sources of arrhythmogenesis. Revista Portuguesa de Cardiologia (English Edition) 2017; 36(12): 945 doi: 10.1016/j.repce.2017.06.012
|
26 |
Williams E. Miranda, Van A. Ngo, Laura L. Perissinotti, Sergei Yu. Noskov. Computational membrane biophysics: From ion channel interactions with drugs to cellular function. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2017; 1865(11): 1643 doi: 10.1016/j.bbapap.2017.08.008
|